Gevokizumab open-label ( DrugBank: Gevokizumab )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
269	化膿性無菌性関節炎・壊疽性膿皮症・アクネ症候群	2

269. 化膿性無菌性関節炎・壊疽性膿皮症・アクネ症候群

---

臨床試験数 : 24 /  薬物数 : 30 - (DrugBank : 12) / 標的遺伝子数 : 15 - 標的パスウェイ数 : 105

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02326740 (ClinicalTrials.gov)	December 2014	22/12/2014	An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum	A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum	Pyoderma Gangrenosum	Drug: gevokizumab;Drug: Placebo;Drug: gevokizumab open-label	XOMA (US) LLC	NULL	Terminated	18 Years	N/A	Both	9	Phase 3	United States;Australia;Canada
2	NCT02315417 (ClinicalTrials.gov)	November 2014	5/12/2014	An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum	A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum	Pyoderma Gangrenosum	Drug: gevokizumab;Drug: Placebo;Drug: gevokizumab open-label	XOMA (US) LLC	NULL	Terminated	18 Years	N/A	Both	16	Phase 3	United States